Gujarat pharma firms vie for share in cancer drug space – Business Standard
Business StandardGujarat pharma firms vie for share in cancer drug spaceBusiness StandardAhmedabad-based Intas Pharmaceuticals had launched a biosimilar version of Rituximab called Mabtas in April this year that is used in treating diseases like leukem…